Biomica
Microbiome-based Therapeutics
StartupBiomica is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2017. Microbiome-based Therapeutics. The company has raised a total of $37M across 2 funding rounds, currently at the A stage. Key investors include Shanghai Healthcare Capital, Evogene, Undisclosed Investor(s). The company has 11-50 employees. Core technologies: Artificial Intelligence, Biologicals, Molecules.
With $37M in total funding, Biomica is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageA
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQRehovot
- DistrictCenter District
- Last Round$20M
- Shanghai Healthcare CapitalLead
- Evogene
- Undisclosed Investor(s)
21 articles covered by sources including www.prnewswire.com,
hitconsultant.net,
www.benzinga.com,
www.biospace.com,
www.wflx.com.
What does Biomica do?
Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders. The company aims to identify and target microbes, metabolites and other microbiome-related components that are key in the etiology of human diseases impacted by the microbiome, using both biological and small-molecule approaches. Biomica’s discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform. PRISM is a proprietary metagenomics analysis platform for functional genomics profiling utilizing internal comprehensive databases. Employing Biomica’s drug discovery approach, PRISM combines a profound understanding of the microbiome and its functions and their intricate relations with the human host. Biomica is a subsidiary of Evogene.
How much funding has Biomica raised?
Biomica has raised $37M in total funding across 2 rounds. The company is currently at the A stage. Key investors include Shanghai Healthcare Capital, Evogene, Undisclosed Investor(s).
What sector is Biomica in?
Biomica operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Artificial Intelligence, Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.
Where is Biomica located?
Biomica is based in Derech Gad Feinstein 13, Rehovot, Israel, Center District.